REQUEST A DEMO
Total
USD $0.00
Search more companies

Tittanmed Corp S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Tittanmed Corp S.A. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Tittanmed Corp S.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on November 23, 2016. Tittanmed Corp S.A. currently employs 3 (2024) people. In its most recent financial highlights, the company reported a net sales revenue drop of 4.69% in 2024. Its’ total assets recorded a negative growth of 3.79%. The net profit margin of Tittanmed Corp S.A. decreased by 3.67% in 2024.

Headquarters
Calle Justino Cornejo, Mz 404
Guayaquil; Guayas;

Contact Details: Purchase the Tittanmed Corp S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Tittanmed Corp S.A. report to view the information.
Registered Capital:
Purchase the Tittanmed Corp S.A. report to view the information.
Financial Auditors:
Purchase the Tittanmed Corp S.A. report to view the information.
Incorporation Date:
November 23, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Tittanmed Corp S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-4.69%
Total operating revenue
-4.69%
Operating profit (EBIT)
-58.4%
EBITDA
-58.4%
Net Profit (Loss) for the Period
-64.64%
Total Assets
-3.79%
Total Equity
6.98%
Operating Profit Margin (ROS)
-3.29%
Net Profit Margin
-3.67%
Return on Equity (ROE)
-18.44%
Quick Ratio
0.06%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?